Mithra Pharmaceuticals S.A.

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP

B6S4RJ106
SEDOL

BYYQZM8
CIK

N/A

mithra.com
LEI:
FIGI: BBG009CK56Q5
MITRA

Mithra Pharmaceuticals S.A.
GICS: 35202010 · Sector: - · Sub-Sector: -
NAME
Mithra Pharmaceuticals S.A.
ISIN
BE0974283153
TICKER
MITRA
MIC
XBRU
REUTERS
MITRA.BR
BLOOMBERG
MITRA BB
EN 728x90
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
In this section you will find transaction histories for short sales.
ai
NALIZER
Short sellers are obliged to report when building up positions from 0.50% and when reducing positions up to 0.50%. If there are open positions >= 0.50% in the reporting registers, these are shown in the following overview.
Nine Short sale positions >= 0.50% are currently registered as reportable-relevant
Date Position Holder Position # Action
06.03.2024 CITADEL SECURITIES (EUROPE) LIMITED 0,56% 1
15.02.2024 Renaissance Technologies LLC 0,50% 1
14.09.2023 Highbridge Capital Management LLC 0,73% 536
23.02.2023 Millennium International Management LP 0,50% 1
05.12.2022 Whitebox Advisors LLP 0,62% 5
23.06.2022 Whitebox Advisors LLC 0,50% 32
27.01.2022 Citadel Advisors Europe Limited 0,57% 25
02.01.2022 Citadel Europe LLP 0,50% 328
04.03.2019 Marshall Wace LLP 0,59% 195
The overview shows all positions and their last reported status. Please note that when reducing positions, falling below the 0.50% limit means that the mandatory reporting obligations no longer have to be applied. As a rule, it can be assumed that the positions have been completely reduced following a longer period of inactivity. Positions < 0.50% are therefore only of limited significance.
Date Position Holder Position # Action
06.03.2024 CITADEL SECURITIES (EUROPE) LIMITED 0,56% 1
15.02.2024 Renaissance Technologies LLC 0,50% 1
14.09.2023 Highbridge Capital Management LLC 0,73% 536
23.02.2023 Millennium International Management LP 0,50% 1
05.12.2022 Whitebox Advisors LLP 0,62% 5
23.06.2022 Whitebox Advisors LLC 0,50% 32
27.01.2022 Citadel Advisors Europe Limited 0,57% 25
02.01.2022 Citadel Europe LLP 0,50% 328
04.03.2019 Marshall Wace LLP 0,59% 195
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements
The information provided in this area is compiled with care and prepared and processed in complex technical process steps. Quality assurance is an integral part of the methods and procedures used. A plausibility check is carried out to the extent that the source data allows. Before further use, especially in the course of any investment decisions, we recommend consulting at least one second independent source for validation.